Showing 871-880 of 1009 results for "".
- Cosmetic Surgery, Procedure Devices Market To Grow By $7.95Bhttps://modernaesthetics.com/news/cosmetic-surgery-procedure-devices-market-expected-to-grow-by-795b-over-next-4-years/2473603/New research forecasts the cosmetic surgery and procedure devices market will grow by $7.95 billion from 2024 to 2028. Technavio estimates the market to increase at a compound annual growth rate of 10.45% over the next four years. An increase of medical conditions that require cos
- US Aesthetic Medicine Market to Reach $136.69 Billion By 2033https://modernaesthetics.com/news/us-aesthetic-medicine-market-to-reach-13669-billion-by-2033/2473602/The US aesthetic medicine market is expected to grow exponentially over the next 9 years. A new market research report projects the industry will reach $136.69 billion by 2033, expanding at a compound annual growth rate (CAGR) of 13.6%. The industry was calculated at $43.38 billio
- 4 Arrested in Cosmetic Surgery Scheme That Left Patients Botchedhttps://modernaesthetics.com/news/4-arrested-in-cosmetic-surgery-scheme-that-left-patients-botched/2473600/Four people have been arrested in a cosmetic surgery scheme that left victims with “various complications” in Port St. Lucie, Florida. Police said the investigation began in May 2022 with a criminal complaint filed by the Department of Health on Cosmetica Plastic Surgery and Anti-Agin
- AVAVA Secures $35M in Financing to Support Expansion of Laser Technologyhttps://modernaesthetics.com/news/avava-secures-35m-in-financing-to-support-expansion-of-laser-technology/2473591/AVAVA, Inc. announced a $35 million funding has been secured for its focus on advancing image-guided intradermal laser products that are safe and effective for all skin tones. The financin
- Exosome Diagnostics and Therapeutics Market Expected to Surgehttps://modernaesthetics.com/news/exosome-diagnostics-and-therapeutics-market-expected-to-surge/2473588/Emerging potential of exosome-based liquid biopsy is a primary factor driving the growth of the market. The Exosome Diagnostics and Therapeutics market is expected to surge from $59 million in 2024 to $6.848 billion by 2032 with a compound annual growth rate of 108.9%. The exosome
- Alma Introduces Alma IQ With World's Most Versatile Aesthetic Workstationhttps://modernaesthetics.com/news/alma-advances-personalization-worlds-most-versatile-aesthetic-workstation-intelligence-skin-analysis-system/2473584/Alma IQ is a custom skin analysis system built to redefine and elevate the patient experience. It’s the latest innovation debuted from Alma, a global leader in energy-based medical and aesthetics solutions. The system has smart technology with 10 light mode, scanning multiple skin
- Dr. Jeanine Downie Discusses Fake Botox in TV Segmenthttps://modernaesthetics.com/news/dr-jeanine-downie-discusses-fake-botox-in-tv-segment/2473578/If public awareness is the key to combatting the counterfeit Botox problem that has been popping up around the country recently, then Modern Aesthetics Editorial Board member Jeanine B. Downie, MD, FAAD, took a big step May 13. Dr. Downie joined anchor Vanessa Freeman on P
- FDA Clears New Indication for UltraClear Laserhttps://modernaesthetics.com/news/fda-clears-new-indication-for-ultraclear-laser/2473577/The U.S. Food and Drug Administration (FDA) cleared a new indication of Acclaro Medical's UltraClear® cold ablative fractional 2910 nm fiber laser, expanding the use of the technology for the treatment of benign pigmented lesions and vascular dyschromia, the company announced i
- Aesthetic Society Names New Presidenthttps://modernaesthetics.com/news/aesthetic-society-names-new-president/2473569/The Aesthetic Society announced the appointment of Kiya Movassaghi, MD, DMD, FACS, a board-certified plastic surgeon from Eugene, Oregon, as its president, saying his leadership will focus on strategically fortifying The Society's position as the global leader in education and innov
- BIOCORNEUM Joins Bioderma Portfoliohttps://modernaesthetics.com/news/biocorneum-joins-bioderma-portfolio/2473567/Nuance Medical announced the successful acquisition of BIOCORNEUM, a silicone gel scar treatment brand previously owned by Sientra, according to a press release. Effective immediately, BIOCORNEUM will become a part of the Biodermis portfolio, Nuance Medical’s brand specializing in silicone